ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN) (the “Company”), reported that its compliance plan, submitted on March 23, 2009, has been accepted by the NYSE Amex (the “Exchange”).
ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN) (the “Company”), reported that its compliance plan, submitted on March 23, 2009, has been accepted by the NYSE Amex (the “Exchange”).
